Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention (Q40780751)

23 September 2017

1 reference

title

Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention (English)

1 reference

23 September 2017

A Leake

1

1 reference

PubMed ID

8241606

23 September 2017

I N Ferrier

series ordinal

2

1 reference

23 September 2017

1 September 1993

1 reference

23 September 2017

1 reference

23 September 2017

3

1 reference

23 September 2017

5

1 reference

23 September 2017

408-427

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-199303050-00003

23 September 2017

0 references

cites work

Thyrotropin releasing hormone content is unchanged in brains of patients with Parkinson disease.

1 reference

12 December 2020

Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease

1 reference

12 December 2020

Do concentrations of neurotransmitters in lumbar CSF reflect cerebral dysfunction in depression?

1 reference

12 December 2020

Reciprocal changes in corticotropin-releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease

1 reference

12 December 2020

Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains

1 reference

12 December 2020

Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes

1 reference

12 December 2020

An update on the neurochemistry of Alzheimer disease

1 reference

12 December 2020

CSF corticotropin-releasing hormone in depressed patients and normal control subjects

1 reference

12 December 2020

Substance P in the substantia nigra

1 reference

12 December 2020

Some effects of an ACTH 4–9 analog (Org 2766) on human performance

1 reference

12 December 2020

Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease.

1 reference

12 December 2020

Diazepam binding inhibitor-like immunoreactivity (DBI-LI) in human CSF. Correlations with neurological disorders

1 reference

12 December 2020

The cholinergic hypothesis--ten years on.

1 reference

12 December 2020

Reductions in corticotropin releasing factor-like immunoreactivity in cerebral cortex in Alzheimer's disease, Parkinson's disease, and progressive supranuclear palsy.

1 reference

12 December 2020

CSF somatostatin-like immunoreactivity in dementia

1 reference

12 December 2020

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.

1 reference

12 December 2020

Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex

1 reference

12 December 2020

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

1 reference

12 December 2020

Huntington's chorea?Measurements of somatostatin, substance P and Cyclic nucleotides in the cerebrospinal fluid

1 reference

12 December 2020

Peptides in the neocortex in Alzheimer's disease and ageing

1 reference

12 December 2020

Biological stability of mRNA isolated from human postmortem brain collections

1 reference

12 December 2020

beta-Endorphin-like immunoreactivity in cerebrospinal fluid of patients with Alzheimer's disease and Parkinson's disease.

1 reference

12 December 2020

Low levels of somatostatin in human CSF mark depressive episodes

1 reference

12 December 2020

Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders.

1 reference

12 December 2020

Neuropeptides in neurological disease

1 reference

12 December 2020

Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients

1 reference

12 December 2020

Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease

1 reference

12 December 2020

Substance P immunoreactivity in the post-mortem parkinsonian brain

1 reference

12 December 2020

The neurobiology of Alzheimer's disease

1 reference

12 December 2020

The influence of agonal status on some neurochemical activities of postmortem human brain tissue

1 reference

12 December 2020

Somatostatin and vasoactive intestinal polypeptide in postmortem brains from patients with Alzheimer-type dementia.

1 reference

12 December 2020

Striosomal organization of substance P-like immunoreactivity in parkinsonian patients

1 reference

12 December 2020

Preservation of [125I]galanin binding sites despite loss of cholinergic neurons to the hippocampus in Alzheimer's disease

1 reference

12 December 2020

Patients with Alzheimer's disease show an increased content of 15 Kdalton somatostatin precursor and a lowered level of tetradecapeptide in their cerebrospinal fluid.

1 reference

12 December 2020

CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression

1 reference

12 December 2020

Regional Brain Concentrations of Neuropeptides in Huntington's Chorea and Schizophrenia

1 reference

12 December 2020

Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.

1 reference

12 December 2020

Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia.

1 reference

12 December 2020

Clinically and neuropathologically distinct form of dementia in the elderly

1 reference

12 December 2020

Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease.

1 reference

12 December 2020

CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects.

1 reference

12 December 2020

A polymorphic DNA marker genetically linked to Huntington's disease

1 reference

12 December 2020

Antidepressant-anxiolytic interaction: Decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants

1 reference

12 December 2020

Role of corticotrophin releasing hormone 41 in depressive illness

1 reference

12 December 2020

Human brain neurochemistry — Some postmortem problems

1 reference

12 December 2020

Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease

1 reference

12 December 2020

Immunocytochemical localization of enkephalin-like immunoreactivity in neurons of human hippocampal formation: effects of ageing and Alzheimer's disease.

1 reference

12 December 2020

Spinal fluid CRF reduction in Alzheimer's disease

1 reference

12 December 2020

Beta-endorphin and somatostatin concentrations in the ventricular cerebrospinal fluid of patients with affective disorder

1 reference

12 December 2020

Neurotensin immunoreactivity in post-mortem brain is increased in Down's syndrome but not in Alzheimer-type dementia.

1 reference

12 December 2020

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

12 December 2020

Enkephalinergic Markers in Substantia Nigra and Caudate Nucleus from Parkinsonian Subjects

1 reference

12 December 2020

Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.

1 reference

12 December 2020

Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease

1 reference

12 December 2020

Substance P-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex

1 reference

12 December 2020

Opioid peptides in Parkinson's disease: effects of dopamine repletion

1 reference

12 December 2020

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

1 reference

12 December 2020

Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro

1 reference

12 December 2020

CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: its relationship to severity of dementia and monoamine metabolites

1 reference

12 December 2020

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

1 reference

12 December 2020

Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases

1 reference

12 December 2020

Immunohistochemical study of neurons containing corticotropin-releasing factor in Alzheimer's disease.

1 reference

12 December 2020

Delta-sleep-inducing peptide (DSIP): an update

1 reference

12 December 2020

Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat.

1 reference

12 December 2020

Immunoreactive somatostatin-28(1-12) is increased in Huntington's disease

1 reference

12 December 2020

Neuropeptides in human cerebrospinal fluid

1 reference

12 December 2020

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

1 reference

12 December 2020

A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease

1 reference

12 December 2020

Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.

1 reference

12 December 2020

Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.

1 reference

12 December 2020

Location of neuronal tangles in somatostatin neurones in Alzheimer's disease

1 reference

12 December 2020

The neurobiology of aging: does it predispose to depression?

1 reference

12 December 2020

Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia

1 reference

12 December 2020

Multicenter trial of naloxone in Alzheimer's disease.

1 reference

12 December 2020

Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels.

1 reference

12 December 2020

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

1 reference

12 December 2020

Investigations with the specific mu-opiate receptor agonist fentanyl in depressive patients: growth hormone, prolactin, cortisol, noradrenaline and euphoric responses

1 reference

12 December 2020

Recent advances in neuropathology

1 reference

12 December 2020

Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain

1 reference

12 December 2020

Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.

1 reference

12 December 2020

Naloxone (Narcan�) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites

1 reference

12 December 2020

Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.

1 reference

12 December 2020

Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease

1 reference

12 December 2020

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

12 December 2020

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

1 reference

12 December 2020

Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients.

1 reference

12 December 2020

Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression

1 reference

12 December 2020

Effects of haloperidol on somatostatin-like immunoreactivity in the CSF of Schizophrenic patients

1 reference

12 December 2020

Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.

1 reference

12 December 2020

Increased TRH content of the basal ganglia in Huntington's disease

1 reference

12 December 2020

Neocortical substance P neurons in the baboon: An immunohistochemical finding

1 reference

12 December 2020

CSF vasopressin concentration is reduced in Alzheimer's disease.

1 reference

12 December 2020

Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers

1 reference

12 December 2020

Cerebrospinal fluid vasopressin in neurological and psychiatric disorders

1 reference

12 December 2020

Corticotropin-releasing factor immunoreactivity in post-mortem brain from depressed suicides.

1 reference

12 December 2020

Neurohypophyseal function in affective illness.

1 reference

12 December 2020

Elevation of immunoreactive CSF TRH in depressed patients

1 reference

12 December 2020

Central ACTH deficit in degenerative and vascular dementia.

1 reference

12 December 2020

Elevated CSF somatostatin concentrations in demented patients parallel improved psychomotor functions induced by integrity-promoting care

1 reference

12 December 2020

Localization of immunoreactive enkephalins in GABA synthesizing neurons of the rat neostriatum

1 reference

12 December 2020

Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain.

1 reference

12 December 2020

Striatal met-enkephalin concentration increases following nigrostriatal denervation.

1 reference

12 December 2020

Vasopressin analog (DDAVP) improves memory in human males.

1 reference

12 December 2020

Neuropeptides in Alzheimer type dementia

1 reference

12 December 2020

Dissociation of neuropeptide Y and somatostatin in Parkinson's disease.

1 reference

12 December 2020

CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.

1 reference

12 December 2020

Regional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects.

1 reference

12 December 2020

Dementia of different etiologies: vasoactive intestinal polypeptide in CSF

1 reference

12 December 2020

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

1 reference

12 December 2020

Somatostatin and dementia in Parkinson's disease

1 reference

12 December 2020

Reduced cortical choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide.

1 reference

12 December 2020

Cerebrospinal fluid neuropeptides in dementia

1 reference

12 December 2020

Cerebrospinal fluid somatostatin and psychiatric illness

1 reference

12 December 2020

Increase in diazepam binding inhibitor-like immunoreactivity (51-70) in Huntington's disease

1 reference

12 December 2020

Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease.

1 reference

12 December 2020

Somatostatin immunoreactivity is reduced in Parkinson's disease dementia with Alzheimer's changes

1 reference

12 December 2020

Thyrotropin-releasing hormone, luteinizing hormone-releasing hormone and substance P immuno-reactivity in post-mortem brain from cases of Alzheimer-type dementia and Down's syndrome.

1 reference

12 December 2020

Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia.

1 reference

12 December 2020

Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity

1 reference

12 December 2020

Somatostatin content and receptors in the cerebral cortex of depressed and control subjects

1 reference

12 December 2020

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

1 reference

12 December 2020

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

1 reference

12 December 2020

High-molecular-weight forms of somatostatin are reduced in Alzheimer's disease and Down's syndrome

1 reference

12 December 2020

Normal pattern of labeling of cerebral cortical corticotropin-releasing factor (CRF) receptors in Alzheimer's disease: evidence from chemical cross-linking studies.

1 reference

12 December 2020

Brain peptides: what, where, and why?

1 reference

12 December 2020

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.

1 reference

12 December 2020

A detailed examination of substance P in pathologically graded cases of Huntington's disease

1 reference

12 December 2020

Decreased level of β-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type

1 reference

12 December 2020

CSF vasopressin and cyclic nucleotide concentrations in senile dementia

1 reference

12 December 2020

Corticotropin-releasing factor immunoreactive neurons persist throughout the brain in Alzheimer's disease

1 reference

12 December 2020

Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus.

1 reference

12 December 2020

Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type

1 reference

12 December 2020

Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy

1 reference

12 December 2020

Aging brain and dementias: changes in central opioids.

1 reference

12 December 2020

Human brain substance P: distribution in controls and Huntington's chorea

1 reference

12 December 2020

CCK receptors and human neurological disease

1 reference

12 December 2020

Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease

1 reference

12 December 2020

Parkinson's disease affects differently Met5- and Leu5-enkephalin in the human brain.

1 reference

12 December 2020

Somatostatin is increased in the basal ganglia in Huntington disease

1 reference

12 December 2020

Alzheimer's disease and the pivotal role of the hypothalamus and the intrinsic opioid system

1 reference

12 December 2020

Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease

1 reference

12 December 2020

Effects of vasopressin on human memory functions.

1 reference

12 December 2020

Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.

1 reference

12 December 2020

Dynorphin levels in parkinsonian patients: Leu5-enkephalin production from either proenkephalin A or prodynorphin in human brain.

1 reference

12 December 2020

Vasoactive intestinal peptide in cerebrospinal fluid

1 reference

12 December 2020

Somatostatin and GHRH: mood and behavioral regulation.

1 reference

12 December 2020

Neuroanatomical aspects of neurotransmitters affected in Alzheimer's disease

1 reference

12 December 2020

Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance

1 reference

12 December 2020

1 reference

12 December 2020

An ACTH 4-9 analog (Org 2766) and cognitive performance: high-dose efficacy and safety in dementia of the Alzheimer's type.

1 reference

12 December 2020

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

1 reference

12 December 2020

Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.

1 reference

12 December 2020

Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy

1 reference

12 December 2020

Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients

1 reference

12 December 2020

Met-enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degeneration

1 reference

12 December 2020

Selective sparing of a class of striatal neurons in Huntington's disease

1 reference

12 December 2020

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

12 December 2020

Failure of vasopressin to enhance memory in a passive avoidance task in rats.

1 reference

12 December 2020

Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease.

1 reference

12 December 2020

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

1 reference

12 December 2020

Decrease in a proenkephalin peptide in cerebrospinal fluid in Huntington's disease and progressive supranuclear palsy.

1 reference

12 December 2020

Methionine enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients

1 reference

12 December 2020

Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.

1 reference

12 December 2020

Naltrexone and Alzheimer's disease.

1 reference

12 December 2020

Y-29794--a non-peptide prolyl endopeptidase inhibitor that can penetrate into the brain

1 reference

12 December 2020

Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type

1 reference

12 December 2020

10.2165/00002512-199303050-00003

Identifiers

DOI

1 reference

PubMed ID

8241606

Dimensions Publication ID

23 September 2017

0 references

1 reference

PubMed ID

8241606